Search

Your search keyword '"Di Mitri, Diletta"' showing total 130 results

Search Constraints

Start Over You searched for: Author "Di Mitri, Diletta" Remove constraint Author: "Di Mitri, Diletta"
130 results on '"Di Mitri, Diletta"'

Search Results

1. NaCl enhances CD8+ T cell effector functions in cancer immunotherapy

2. Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defines hyperactivated Tregs as a potential therapeutic target

5. IL-23 secreted by myeloid cells drives castration-resistant prostate cancer

7. Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer

9. MP14-11 SINGLE CELL-BASED IMMUNE PROFILING OF THE TUMOR AND ITS IMMUNE MICROENVIRONMENT REVEALED DIFFERENCES BETWEEN NMIBC AND MIBC: IMPLICATION FOR IMMUNO-THERAPY

11. NaCl enhances CD8+T cell effector functions in cancer immunotherapy

14. Multimodal single-cell profiling of intrahepatic cholangiocarcinoma defines hyperactivated Tregs as a potential therapeutic target

15. Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer

16. Tumour-infiltrating Gr-[1.sup.+] myeloid cells antagonize senescence in cancer

17. Publisher Correction: Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer

22. PD59-02 HIGH DIMENSIONAL PROFILING OF THE IMMUNE MICROENVIRONMENT IN PROSTATE CANCER REVEALED NOVEL TUMOR-DRIVEN ALTERATIONS IN INFILTRATING SUBSETS

23. High-dimensional single cell-based immune profiling of the tumor immune microenvironment in prostate cancer.

24. Enhancing chemotherapy efficacy in Pten-deficient prostate tumors by activating the senescence-associated antitumor immunity

25. T regulatory cells are markers of disease activity in multiple sclerosis patients

26. Re-education of Tumor-Associated Macrophages by CXCR2 Blockade Drives Senescence and Tumor Inhibition in Advanced Prostate Cancer

31. A chemogenomic screening identifies CK2 as a target for pro-senescence therapy in PTEN-deficient tumours

34. Enhancing Chemotherapy Efficacy in Pten -Deficient Prostate Tumors by Activating the Senescence-Associated Antitumor Immunity

35. CD28 ligation in the absence of TCR stimulation up-regulates IL-17A and pro-inflammatory cytokines in relapsing-remitting multiple sclerosis T lymphocytes

36. Reversible Senescence in Human CD4+CD45RA+CD27− Memory T Cells

37. T Regulatory Cells Are Markers of Disease Activity in Multiple Sclerosis Patients

38. Efficacy of a Nanocochleate-Encapsulated 3,5-Diaryl-s-Triazole Derivative in a Murine Model of Graft-Versus-Host Disease

39. Tumour-infiltrating Gr-1+ myeloid cells antagonize senescence in cancer.

40. Dual role of endolysosomal two-pore channel two (tpc2) in malignant traits of melanoma cells.

41. Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer

42. CD49d provides access to “untouched” human Foxp3+Treg free of contaminating effector cells

43. Expression of ectonucleotidase CD39 by Foxp3+Treg cells: hydrolysis of extracellular ATP and immune suppression

44. Immunology and Immunotherapeutic Approaches for Advanced Renal Cell Carcinoma: A Comprehensive Review.

45. Unravelling the role of TPC2/calcium signaling-dependent autophagy in melanoma microenvironment remodelling.

47. Heterotypic signaling between tumor cells and lipid-loaded macrophages drives tumor progression and resistance to therapy in cancer

49. T regulatory cells are markers of disease activity in multiple sclerosis patients

50. Enhancing chemotherapy efficacy in Pten-deficient prostate tumors by activating the senescence-associated antitumor immunity

Catalog

Books, media, physical & digital resources